879 filings
Page 27 of 44
UPLOAD
k0cwiwmc
17 Sep 10
Letter from SEC
12:00am
8-K
lsmxwl
15 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
2vlxdv
25 Aug 10
Departure of Directors or Certain Officers
12:00am
8-K
na7jz1 7sfpjndue8
4 Aug 10
Discovery Labs Provides Business Update and Reports Second Quarter 2010 Financial Results
12:00am
8-K
6hv9r5wwz9uu
9 Jul 10
Departure of Directors or Certain Officers
12:00am
424B5
pax uyx0anxuzgblrlag
18 Jun 10
Prospectus supplement for primary offering
12:00am
8-K
8n1jcu0csddy7x
17 Jun 10
Discovery Labs Prices $10.0 Million Public Offering of
12:00am
424B5
r7k6d6g ah
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
uiwshadw
15 Jun 10
Prospectus supplement
12:00am
8-K
bg3c5d2z3
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
n6pbdxzoblcittaa2mxk
9 Jun 10
Discovery Labs Receives FDA Guidance Regarding Preclinical Program to
12:00am
8-K
ljfoczf2m98k36
9 Jun 10
Discovery Labs Reports Preliminary Results from Phase 2 Clinical Trial of Surfaxin in Pediatric Acute Respiratory Failure
12:00am
8-K
iaeu1lk
4 Jun 10
Discovery Labs Announces Listing Transfer to NASDAQ Capital Market
12:00am
8-K
izraxtgtlziz8bi
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am
8-K
3dz5kv6ugguml ns
29 Apr 10
Other Events
12:00am
424B5
jwj5w0n6
28 Apr 10
Prospectus supplement for primary offering
12:00am
8-K
tdmw yhp5qw
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am